Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» immunology
immunology
Another 5 years of dominance: Oncology, immunology will extend their lead as pharma's top fields through 2025
Fierce Pharma
Fri, 05/7/21 - 10:39 am
biosimilars
oncology
immunology
autoimmune disease
cancer
Sanofi begins three-year immunology R&D tie-up with Stanford
Pharmaforum
Thu, 05/6/21 - 10:45 am
Sanofi
Sanford
R&D
immunology
inflammation
New name, new board, new focus: AltruBio relaunches with $63M series A
Fierce Biotech
Thu, 04/15/21 - 10:04 am
AltruBio
immunology
AbGenomics
Pfizer may have a lot going on in immunology, but all its drugs could be beaten by rivals: analyst
Fierce Pharma
Thu, 07/9/20 - 10:21 pm
Pfizer
immunology
abrocitinib
Xeljanz
PF-06651600
Out to revive R&D, a resurgent Sanofi pays $150M cash to partner up with a pioneering protein degradation player
Endpoints
Thu, 07/9/20 - 10:57 am
Sanofi
protein degradation
immunology
R&D
Kymera
AbbVie beefs up the immunology pipeline, betting up to $865M on a PhII-ready drug — and fueling a biotech stock frenzy
Endpoints
Thu, 06/18/20 - 10:55 am
AbbVie
Mitchell Gold
Dendreon
ALPN-101
immunology
Alpine Immune Sciences
lupus
FDA and Immunology Experts Call for Flexible Trial Design for Pandemic Vaccines
BioSpace
Tue, 04/21/20 - 12:08 am
vaccines
clinical trials
FDA
immunology
pandemic
COVID-19
AbbVie's plan to replace Humira is ahead of schedule
BioPharma Dive
Fri, 02/7/20 - 11:48 pm
AbbVie
Humira
Skyrizi
immunology
AbbVie and Scripps Research Enter Research Partnership in Cancer, Immunology, Neurology and Fibrosis
BioSpace
Mon, 12/9/19 - 11:18 pm
AbbVie
Scripps Research Institute
cancer
immunology
fibrosis
Numero quattro: Immunology experts at deal-focused IFM line up $55.5M for the next leg of their drug exploration journey
Endpoints
Mon, 12/2/19 - 09:47 am
IFM Therapeutics
immunology
Atlas Ventures
Lilly counts on growing markets to boost lagging Taltz, Trulicity
Fierce Pharma
Thu, 10/24/19 - 10:55 am
Eli Lilly
Trulicity
Taltz
immunology
type 2 diabetes
AbbVie's Latest FDA Approval Is Its Most Important Immunology Win Since Humira
Motley Fool
Tue, 08/20/19 - 10:39 am
AbbVie
Rinvoq
Humira
immunology
5 Signs of Life in Johnson & Johnson's Second-Quarter Earnings Report
Yahoo/Motley Fool
Thu, 07/18/19 - 10:09 am
JNJ
earnings
immunology
devices
Sanofi Cuts a Whopping 38 R&D Programs to Refocus on Cancer, Immunology, and Rare Diseases
BioSpace
Thu, 02/7/19 - 11:05 am
Sanofi
Rare Diseases
immunology
cancer
R&D
J&J still sees plenty of opportunity in crowded immunology markets—starting with psoriasis
Fierce Pharma
Wed, 01/9/19 - 12:56 pm
JNJ
JPMHC 2019
immunology
psoriasis
Tremfya
Forget Remicade -- Here's How Johnson & Johnson Plans to Grow
Motley Fool
Wed, 03/14/18 - 11:34 am
JNJ
Stelara
Zytiga
Darzalex
oncology
immunology
ABBV to Focus on Advancing Late-Stage Immunology Research in 2018
Market Realist
Thu, 02/8/18 - 11:17 am
AbbVie
R&D
immunology
Upadacitinib
risankizumab
Eli Lilly, sporting a lower tax rate, scouts smaller deals in immunology, cancer
Fierce Pharma
Thu, 01/11/18 - 11:56 pm
Eli Lilly
M&A
immunology
Charles River buys KWS BioTest for $20M, gaining immunology discovery capacity and a UK footprint
Endpoints
Thu, 01/11/18 - 09:53 am
Charles River Laboratories
KWS BioTest
M&A
immunology
R&D
King cancer: The top 10 therapeutic areas in biopharma R&D
Endpoints
Tue, 07/18/17 - 10:49 pm
R&D
cancer
neurology
infection
immunology
cardiovascular disease
diabetes
Pages
« first
‹ previous
1
2
3
next ›
last »